MAGNEVIST Side Effects

6963575-4 | Arthralgia, Arthritis, Back Pain, Blister, Dry Skin, Erythema, Joint Contracture, Mobility Decreased, Nephrogenic Systemic Fibrosis
on Aug 16, 2010 Female patient from UNITED STATES , 62 years of age, weighting 249.1 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), back pain (What is back pain?), blister, dry skin, erythema, joint contracture, mobility decreased, nephrogenic systemic fibrosis. Magnevist dosage: ^2ml/kg^. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LASIX (View Lasix Review and Lasix Label ), IMDUR (View Imdur Review and Imdur Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), BENADRYL (View Benadryl Review and Benadryl Label ), PERCOCET (View Percocet Review and Percocet Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6963573-0 | Chest Pain, Retching, Vomiting
Patient was taking Magnevist (View Usage). Patient had the following side effects: chest pain (What is chest pain?), retching, vomiting on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 149.9 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 15 Ml Unit Dose: 15 Ml.

6963572-9 | Bradycardia, Dysarthria, Hyperhidrosis, Vomiting
Adverse event was reported on Aug 30, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging and. Location: AUSTRALIA , 36 years of age, After Magnevist was administered, patient had the following side effects: bradycardia, dysarthria, hyperhidrosis, vomiting.

6963571-7 | Anhedonia, Anxiety, Back Pain, Emotional Distress, Exfoliative Rash, Gait Disturbance, Hyperkeratosis, Joint Range Of Motion Decreased, Muscle Fatigue
on Aug 24, 2010 Female patient from UNITED STATES , 33 years of age, weighting 194.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, nuclear magnetic resonance imaging abdominal, gastrooesophageal reflux disease, wheezing and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, anxiety (What is anxiety?), back pain (What is back pain?), emotional distress, exfoliative rash, gait disturbance, hyperkeratosis, joint range of motion decreased, muscle fatigue. Magnevist dosage: . During the same period patient was treated with OMNISCAN (Total Daily Dose: 40 Ml) (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ).


6963570-5 | Burning Sensation, Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness
on Aug 23, 2010 Female patient from UNITED STATES , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: burning sensation, erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6963568-7 | Anxiety, Arthralgia, Asthenia, Blister, Deformity, Dry Skin, Fatigue, Fibrosis
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: anxiety (What is anxiety?), arthralgia, asthenia, blister, deformity, dry skin, fatigue, fibrosis on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 220.5 lb, was diagnosed with imaging procedure, nuclear magnetic resonance imaging and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ).

6961149-2 | Anxiety, Arthralgia, Asthenia, Blister, Deformity, Dry Skin, Fatigue, Fibrosis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with imaging procedure, nuclear magnetic resonance imaging and. Location: UNITED STATES , 39 years of age, weighting 220.5 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), arthralgia, asthenia, blister, deformity, dry skin, fatigue, fibrosis. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ).

6961148-0 | Burning Sensation, Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness
on Aug 23, 2010 Female patient from UNITED STATES , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: burning sensation, erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6959025-4 | Nephrogenic Systemic Fibrosis
on Aug 24, 2010 Male patient from DENMARK , weighting 165.3 lb, was diagnosed with scan with contrast, hypertension, hyperparathyroidism, mineral supplementation, constipation (What is constipation?) and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: nephrogenic systemic fibrosis. Magnevist dosage: . During the same period patient was treated with DIURAL (View Diural Review and Diural Label ), ETALPHA (View Etalpha Review and Etalpha Label ), APURIN (View Apurin Review and Apurin Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), SELOZOK (View Selozok Review and Selozok Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6958668-1 | Chest Discomfort
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: Total Daily Dose: 15 Ml Unit Dose: 15 Ml.

6958667-X | Chest Discomfort
Adverse event was reported on Jul 29, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 15 Ml Unit Dose: 15 Ml) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 36 years of age, Patient had the following side effects: chest discomfort.

6958643-7 | Asthenia, Erythema, Livedo Reticularis, Mobility Decreased, Nephrogenic Systemic Fibrosis, Pain, Pruritus, Rash Papular, Skin Discolouration
on Aug 13, 2010 Female patient from UNITED STATES , 72 years of age, weighting 116.8 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: asthenia, erythema, livedo reticularis, mobility decreased, nephrogenic systemic fibrosis, pain (What is pain?), pruritus, rash papular, skin discolouration. Magnevist dosage: Total Daily Dose: 15 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

6958642-5 | Arthralgia, Arthritis, Back Pain, Blister, Dry Skin, Erythema, Joint Contracture, Mobility Decreased, Nephrogenic Systemic Fibrosis
on Aug 16, 2010 Female patient from UNITED STATES , 62 years of age, weighting 249.1 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), back pain (What is back pain?), blister, dry skin, erythema, joint contracture, mobility decreased, nephrogenic systemic fibrosis. Magnevist dosage: ^2ml/kg^. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LASIX (View Lasix Review and Lasix Label ), IMDUR (View Imdur Review and Imdur Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), BENADRYL (View Benadryl Review and Benadryl Label ), PERCOCET (View Percocet Review and Percocet Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6956469-1 | Areflexia, Asthenia, Contusion, Dry Skin, Dupuytren's Contracture Operation, Erythema, Extravasation, Extremity Contracture, Gait Disturbance
Patient was taking Magnevist (View Usage). Patient had the following side effects: areflexia, asthenia, contusion, dry skin, dupuytren's contracture operation, erythema, extravasation, extremity contracture, gait disturbance on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 211.6 lb, was diagnosed with nuclear magnetic resonance imaging abdominal, angiogram and. Magnevist dosage: Total Daily Dose: 18 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (Total Daily Dose: 20 Ml) (View Optimark Review and Optimark Label ).

6956468-X | Asthenia, Erythema, Livedo Reticularis, Mobility Decreased, Nephrogenic Systemic Fibrosis, Pain, Pruritus, Rash Papular, Skin Discolouration
Adverse event was reported on Aug 13, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 15 Ml) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 72 years of age, weighting 116.8 lb, After Magnevist was administered, patient had the following side effects: asthenia, erythema, livedo reticularis, mobility decreased, nephrogenic systemic fibrosis, pain (What is pain?), pruritus, rash papular, skin discolouration. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

6956465-4 | Burning Sensation, Dry Skin, Exfoliative Rash, Joint Range Of Motion Decreased, Joint Stiffness, Limb Discomfort, Muscle Tightness, Musculoskeletal Discomfort, Musculoskeletal Stiffness
on Aug 10, 2010 Female patient from UNITED STATES , 51 years of age, weighting 112.4 lb, was diagnosed with nuclear magnetic resonance imaging abdominal and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, dry skin, exfoliative rash, joint range of motion decreased, joint stiffness, limb discomfort, muscle tightness, musculoskeletal discomfort, musculoskeletal stiffness. Magnevist dosage: Total Daily Dose: 10 Ml.

6956462-9 | Pruritus, Urticaria
on Aug 17, 2010 Male patient from UNITED STATES , 52 years of age, was treated with Magnevist (View Usage). Patient had the following side effects: pruritus, urticaria. Magnevist dosage: As Used: 20 Ml.

6956457-5 | Urticaria
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: urticaria on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 41 years of age, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: Total Daily Dose: 14 Ml.

6956449-6 | Aggression, Anaphylactic Reaction, Confusional State, Dyspnoea, Fall, Flushing, Lethargy, Urinary Incontinence
Adverse event was reported on Aug 25, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 35 years of age, weighting 339.5 lb, Patient experienced the following unwanted or unexpected effects: aggression, anaphylactic reaction, confusional state, dyspnoea, fall (What is fall?), flushing, lethargy, urinary incontinence (What is urinary incontinence?). Patient was hospitalized.

6956447-2 | Activities Of Daily Living Impaired, Arthralgia, Asthenia, Back Pain, Burning Sensation, Deformity, Groin Pain, Hypoaesthesia, Joint Range Of Motion Decreased
on Aug 10, 2010 Female patient from UNITED STATES , 55 years of age, weighting 227.1 lb, was diagnosed with diagnostic procedure, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: activities of daily living impaired, arthralgia, asthenia, back pain (What is back pain?), burning sensation, deformity, groin pain, hypoaesthesia, joint range of motion decreased. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), ALLEGRA (View Allegra Review and Allegra Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6945535-2 | Areflexia, Asthenia, Contusion, Dry Skin, Dupuytren's Contracture Operation, Erythema, Extravasation, Extremity Contracture, Gait Disturbance
on Aug 12, 2010 Male patient from UNITED STATES , 53 years of age, weighting 211.6 lb, was diagnosed with nuclear magnetic resonance imaging abdominal, angiogram and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: areflexia, asthenia, contusion, dry skin, dupuytren's contracture operation, erythema, extravasation, extremity contracture, gait disturbance. Magnevist dosage: Total Daily Dose: 18 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (Total Daily Dose: 20 Ml) (View Optimark Review and Optimark Label ).

6942535-3 | Urticaria
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with nuclear magnetic resonance imaging brain and. Magnevist dosage: As Used: 16 Ml Unit Dose: 20 Ml.

6942469-4 | Burning Sensation, Erythema, Nephrogenic Systemic Fibrosis, Ocular Icterus, Oedema, Oedema Peripheral, Pain In Extremity, Peau D'orange, Rash
Adverse event was reported on Aug 17, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging abdominal and. Location: UNITED STATES , 51 years of age, weighting 200.6 lb, Patient had the following side effects: burning sensation, erythema, nephrogenic systemic fibrosis, ocular icterus, oedema, oedema peripheral, pain in extremity, peau d'orange, rash (What is rash?). During the same period patient was treated with OPTIMARK (As Used: 40 Ml) (View Optimark Review and Optimark Label ), OMNISCAN (As Used: 20 Ml) (View Omniscan Review and Omniscan Label ), COREG (View Coreg Review and Coreg Label ).

6942468-2 | Burning Sensation, Dry Skin, Exfoliative Rash, Joint Range Of Motion Decreased, Joint Stiffness, Limb Discomfort, Muscle Tightness, Musculoskeletal Discomfort, Musculoskeletal Stiffness
on Aug 10, 2010 Female patient from UNITED STATES , 51 years of age, weighting 112.4 lb, was diagnosed with nuclear magnetic resonance imaging abdominal and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: burning sensation, dry skin, exfoliative rash, joint range of motion decreased, joint stiffness, limb discomfort, muscle tightness, musculoskeletal discomfort, musculoskeletal stiffness. Magnevist dosage: Total Daily Dose: 10 Ml.

6942467-0 | Anhedonia, Anxiety, Bone Pain, Deformity, Emotional Distress, Joint Stiffness, Mobility Decreased, Nephrogenic Systemic Fibrosis
on Aug 19, 2010 Female patient from UNITED STATES , 54 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, anxiety (What is anxiety?), bone pain, deformity, emotional distress, joint stiffness, mobility decreased, nephrogenic systemic fibrosis. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ).

6941304-8 | Urticaria
Patient was taking Magnevist (View Usage). Patient had the following side effects: urticaria on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , 21 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: . During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), XANAX (View Xanax Review and Xanax Label ).

6940571-4 | Dyspnoea, Hyperhidrosis
Adverse event was reported on Aug 18, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: As Used: 20 Ml Unit Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging abdominal and. Location: UNITED STATES , 58 years of age, After Magnevist was administered, patient had the following side effects: dyspnoea, hyperhidrosis.

6940567-2 | Eye Swelling, Nausea, Pruritus, Sneezing, Swelling Face
on Aug 17, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with neoplasm and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, nausea (What is nausea?), pruritus, sneezing, swelling face. Magnevist dosage: . Patient was hospitalized.

6940560-X | Activities Of Daily Living Impaired, Arthralgia, Asthenia, Back Pain, Burning Sensation, Deformity, Groin Pain, Hypoaesthesia, Joint Range Of Motion Decreased
on Aug 10, 2010 Female patient from UNITED STATES , 55 years of age, weighting 227.1 lb, was diagnosed with diagnostic procedure, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: activities of daily living impaired, arthralgia, asthenia, back pain (What is back pain?), burning sensation, deformity, groin pain, hypoaesthesia, joint range of motion decreased. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), ALLEGRA (View Allegra Review and Allegra Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6938544-0 | Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness, Muscle Contracture
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness, muscle contracture on Aug 13, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6938543-9 | Cough, Nasal Congestion, Pharyngeal Oedema, Swollen Tongue, Throat Tightness
Adverse event was reported on Aug 16, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 20 Ml) was diagnosed with angiogram and. Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: cough, nasal congestion, pharyngeal oedema, swollen tongue, throat tightness. Patient was hospitalized.

6938533-6 | Dry Skin, Joint Range Of Motion Decreased, Lichenification, Motor Dysfunction, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis, Oedema, Oedema Peripheral, Pain
on Aug 05, 2010 Male patient from UNITED STATES , 79 years of age, weighting 152.1 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: dry skin, joint range of motion decreased, lichenification, motor dysfunction, musculoskeletal stiffness, nephrogenic systemic fibrosis, oedema, oedema peripheral, pain (What is pain?). Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ).

6938532-4 | Anhedonia, Anxiety, Bone Pain, Dry Skin, Emotional Distress, Injury, Joint Range Of Motion Decreased, Mobility Decreased, Muscular Weakness
on Aug 09, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: anhedonia, anxiety (What is anxiety?), bone pain, dry skin, emotional distress, injury, joint range of motion decreased, mobility decreased, muscular weakness. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ).

6938531-2 | Abasia, Anhedonia, Arthralgia, Deformity, Emotional Distress, Erythema, Extremity Contracture, Hypoaesthesia
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, anhedonia, arthralgia, deformity, emotional distress, erythema, extremity contracture, hypoaesthesia on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 105.8 lb, was diagnosed with venogram, nuclear magnetic resonance imaging and. Magnevist dosage: As Used: 15 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), EPOGEN (With Dialysis) (View Epogen Review and Epogen Label ), PROGRAF (View Prograf Review and Prograf Label ).

6938527-0 | Deformity, Joint Stiffness, Joint Swelling, Mobility Decreased, Nephrogenic Systemic Fibrosis, Oedema, Oedema Peripheral, Pain
Adverse event was reported on Aug 16, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging abdominal, renal failure and. Location: UNITED STATES , 79 years of age, weighting 169.8 lb, Patient had the following side effects: deformity, joint stiffness, joint swelling, mobility decreased, nephrogenic systemic fibrosis, oedema, oedema peripheral, pain (What is pain?). During the same period patient was treated with OMNISCAN (As Used: 20 Ml) (View Omniscan Review and Omniscan Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SENSIPAR (View Sensipar Review and Sensipar Label ), FOSRENOL (Total Daily Dose: 3 Df) (View Fosrenol Review and Fosrenol Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

6937531-6 | Urticaria
on Aug 23, 2010 Male patient from UNITED STATES , 52 years of age, weighting 227.3 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: urticaria. Magnevist dosage: 20ml One Time Iv.

6936117-7 | Nephrogenic Systemic Fibrosis
on Aug 12, 2010 Male patient from DENMARK , weighting 165.3 lb, was diagnosed with scan with contrast, hypertension, hyperparathyroidism, mineral supplementation, constipation (What is constipation?) and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: nephrogenic systemic fibrosis. Magnevist dosage: . During the same period patient was treated with DIURAL (View Diural Review and Diural Label ), ETALPHA (View Etalpha Review and Etalpha Label ), APURIN (View Apurin Review and Apurin Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), SELOZOK (View Selozok Review and Selozok Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6936042-1 | Lacrimation Increased, Pruritus, Sneezing
Patient was taking Magnevist (View Usage). Patient had the following side effects: lacrimation increased, pruritus, sneezing on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 24 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: Total Daily Dose: 15 Ml.

6936038-X | Chest Discomfort, Dysphagia, Headache, Palpitations
Adverse event was reported on Aug 04, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: Total Daily Dose: 14 Ml Unit Dose: 15 Ml) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , 47 years of age, weighting 138.9 lb, After Magnevist was administered, patient had the following side effects: chest discomfort, dysphagia, headache (What is headache?), palpitations. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6935997-9 | Erythema, Extremity Contracture, Fibrosis, Joint Contracture, Joint Lock, Joint Range Of Motion Decreased, Joint Stiffness, Muscle Contracture
on Aug 13, 2010 Female patient from UNITED STATES , 33 years of age, weighting 191.8 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, extremity contracture, fibrosis, joint contracture, joint lock, joint range of motion decreased, joint stiffness, muscle contracture. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), PROHANCE (Total Daily Dose: 20 Ml) (View Prohance Review and Prohance Label ), MULTIHANCE (View Multihance Review and Multihance Label ), GABITRIL (View Gabitril Review and Gabitril Label ), RENAGEL (As Used: 800 Mg Unit Dose: 800 Mg) (View Renagel Review and Renagel Label ).

6935996-7 | Anhedonia, Erythema, Joint Contracture, Joint Range Of Motion Decreased, Ligament Disorder, Muscle Tightness, Musculoskeletal Stiffness, Myalgia, Nephrogenic Systemic Fibrosis
on Aug 05, 2010 Male patient from UNITED STATES , 38 years of age, weighting 174.2 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). Patient had the following side effects: anhedonia, erythema, joint contracture, joint range of motion decreased, ligament disorder, muscle tightness, musculoskeletal stiffness, myalgia, nephrogenic systemic fibrosis. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), OPTIMARK (View Optimark Review and Optimark Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LANTUS (View Lantus Review and Lantus Label ), LASIX (View Lasix Review and Lasix Label ).

6935994-3 | Abasia, Anhedonia, Arthralgia, Deformity, Emotional Distress, Erythema, Extremity Contracture, Hypoaesthesia
Patient was taking Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: abasia, anhedonia, arthralgia, deformity, emotional distress, erythema, extremity contracture, hypoaesthesia on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 105.8 lb, was diagnosed with venogram, nuclear magnetic resonance imaging and. Magnevist dosage: As Used: 15 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), EPOGEN (With Dialysis) (View Epogen Review and Epogen Label ), PROGRAF (View Prograf Review and Prograf Label ).

6935990-6 | Anhedonia, Anxiety, Bone Pain, Dry Skin, Emotional Distress, Injury, Joint Range Of Motion Decreased, Mobility Decreased, Muscular Weakness
Adverse event was reported on Aug 09, 2010 by a Male patient taking Magnevist (View Usage) (Dosage: ) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: anhedonia, anxiety (What is anxiety?), bone pain, dry skin, emotional distress, injury, joint range of motion decreased, mobility decreased, muscular weakness. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ).

6933697-2 | Anaphylactic Shock, Chest Pain, Dyspnoea, Respiratory Arrest, Sneezing, Vomiting
on Aug 13, 2010 Male patient from UNITED STATES , 38 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). Patient had the following side effects: anaphylactic shock, chest pain (What is chest pain?), dyspnoea, respiratory arrest, sneezing, vomiting. Magnevist dosage: As Used: 14 Ml Unit Dose: 20 Ml. Patient was hospitalized.

6933696-0 | Asthenia, Erythema, Livedo Reticularis, Mobility Decreased, Nephrogenic Systemic Fibrosis, Pain, Pruritus, Rash Papular, Skin Discolouration
on Aug 05, 2010 Female patient from UNITED STATES , 72 years of age, weighting 116.8 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: asthenia, erythema, livedo reticularis, mobility decreased, nephrogenic systemic fibrosis, pain (What is pain?), pruritus, rash papular, skin discolouration. Magnevist dosage: Total Daily Dose: 15 Ml. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ).

6933695-9 | Arthralgia, Asthenia, Atrial Fibrillation, Diarrhoea, Dizziness, Dysuria, Incontinence, Lethargy
Patient was taking Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, asthenia, atrial fibrillation (What is atrial fibrillation?), diarrhoea, dizziness (What is dizziness?), dysuria, incontinence, lethargy on Aug 13, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with nuclear magnetic resonance imaging and. Magnevist dosage: .

6933693-5 | Dyspnoea, Hyperhidrosis
Adverse event was reported on Aug 12, 2010 by a Female patient taking Magnevist (View Usage) (Dosage: As Used: 20 Ml Unit Dose: 20 Ml) was diagnosed with nuclear magnetic resonance imaging abdominal and. Location: UNITED STATES , 58 years of age, Patient had the following side effects: dyspnoea, hyperhidrosis.

6933692-3 | Dry Skin, Joint Range Of Motion Decreased, Lichenification, Motor Dysfunction, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis, Oedema, Oedema Peripheral, Pain
on Aug 05, 2010 Male patient from UNITED STATES , 79 years of age, weighting 152.1 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Magnevist (View Usage). After Magnevist was administered, patient had the following side effects: dry skin, joint range of motion decreased, lichenification, motor dysfunction, musculoskeletal stiffness, nephrogenic systemic fibrosis, oedema, oedema peripheral, pain (What is pain?). Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ).

6933691-1 | Anhedonia, Erythema, Joint Contracture, Joint Range Of Motion Decreased, Ligament Disorder, Muscle Tightness, Musculoskeletal Stiffness, Myalgia, Nephrogenic Systemic Fibrosis
on Aug 05, 2010 Male patient from UNITED STATES , 38 years of age, weighting 174.2 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Magnevist (View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, erythema, joint contracture, joint range of motion decreased, ligament disorder, muscle tightness, musculoskeletal stiffness, myalgia, nephrogenic systemic fibrosis. Magnevist dosage: . During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), OPTIMARK (View Optimark Review and Optimark Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LANTUS (View Lantus Review and Lantus Label ), LASIX (View Lasix Review and Lasix Label ).

6932422-9 | Anhedonia, Anxiety, Back Pain, Emotional Distress, Exfoliative Rash, Gait Disturbance, Hyperkeratosis, Joint Range Of Motion Decreased, Muscle Fatigue
Patient was taking Magnevist (View Usage). Patient had the following side effects: anhedonia, anxiety (What is anxiety?), back pain (What is back pain?), emotional distress, exfoliative rash, gait disturbance, hyperkeratosis, joint range of motion decreased, muscle fatigue on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 194.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, nuclear magnetic resonance imaging abdominal, gastrooesophageal reflux disease, wheezing and. Magnevist dosage: . During the same period patient was treated with OMNISCAN (Total Daily Dose: 40 Ml) (View Omniscan Review and Omniscan Label ), OPTIMARK (View Optimark Review and Optimark Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ).